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Abstract The Lewis X (Lex) bearing glycolipids were notice-
ably increased in amounts during the course of neural
differentiation of P19 EC cells induced by retinoic acid (RA,
all-trans form). Applying neoglycolipid technology and in situ
TLC-LSIMS, the oligosaccharide chains of these scarce Lex
bearing glycolipids were partially characterized after released
by endoglycoceramidase and subsequent conversion into neogly-
colipids. In order to understand the enzymatic basis for the
expression of Lex bearing glycolipids, we measured glycolipid,
glycoprotein and oligosaccharide fucosyltransferase (Fuc-T)
activities using appropriate substrates in P19 EC cells with or
without RA treatment. All three Fuc-Ts were increased after
RA treatment and the highest activity was in the differentiated
neural cells. We then investigated the two possible Fuc-T genes
that might be responsible for these changes using RT-PCR
analysis. Mouse Fuc-TIX (mFuc-TIX) transcript was detected in
all cell types but it was only strongly expressed in RA-induced
aggregates and neural cells. In the case of mouse Fuc-TIV
(mFuc-TIV) gene, its transcript was only detectable in RA-
induced aggregates and not found in either undifferentiated or
RA-induced neural cells. These results strongly support that
RA induces only a transient expression of the mFuc-TIV gene
in cell aggregates but a more persistent expression of the mFuc-
TIX gene at the transcription level throughout neural cell
differentiation. The mFuc-TIX gene is probably the main cause
for the increased expression of Lex glycoconjugates during neural
differentiation of P19 EC cells. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The expression of Lewis X (Lex) carbohydrate epitope, 3-
fucosyl N-acetyllactosamine, can be recognized by a number
of monoclonal antibodies (MAbs), namely SSEA-1 [1^3],
FORSE-1 [4], CD-15 [5,6] and L5 [7]. It is widely distributed
in many tissues but there are distinctive di¡erences in expres-
sion between species, such as their expression on granulocytes
of human but not on those of mouse, rat, rabbit or pig [8]. It
is also involved in many cell^cell interaction systems, such as
in developing mouse embryo and compaction of mouse em-
bryo of embryonal carcinoma F9 embryonic carcinoma (EC)
cells [2,9], di¡erentiation of TERA-2-derived human embry-
onal carcinoma cells [10,11], and in early neural development
of chick embryo [6]. Two cloned mouse K1,3-fucosyltransfer-
ases (mFuc-Ts) : mFuc-TIV [12,13] and mFuc-TIX [14] have
been shown to be responsible for the synthesis of Lex epitope
in vitro. The mFuc-TIX transcript was detected in neural cells
but not in glial cells including astrocytes [14] while the mFuc-
TIV transcript was not expressed in brain but abundantly
expressed in other tissues [12,14]. These observations suggest
that mFuc-TIX and not mFuc-TIV participates in Lex syn-
thesis in neurons and may also be developmentally regulated
[14]. P19 EC cells have been shown to be useful in studying
early stages of neural di¡erentiation and they di¡erentiate into
postmitotic neurons capable of synaptic formation upon stim-
ulation with retinoic acid (RA) while muscle cells are formed
when stimulated with dimethyl sulfoxide [15^17]. In our pre-
vious study of neural di¡erentiation using P19 EC cells, we
showed that RA also induced the expression of synthases of
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acidic glycolipids in the ganglioside biosynthetic pathway [18].
In the present study, structures of the neutral glycolipids bear-
ing the Lex epitope derived from three P19 EC cell types (un-
treated, RA-induced aggregates and di¡erentiated neural cells)
were analyzed and their immunoactivities measured. Due to
limited amounts of glycolipids available and the complexity in
both sugar chains and ceramide (Cer) moieties, glycolipids
were converted into neoglycolipids before analysis. This elim-
inates distribution of the same sugar chain among di¡erent
fractions bearing di¡erent Cers, and hence increases the sen-
sitivity of both structural and immunostaining detection. We
also measured Fuc-T activities which were responsible for the
synthesis of Lex epitope on di¡erent glycoconjugates using
appropriate substrates in these cells. In addition, we investi-
gated the transcripts of two K1,3-Fuc-T genes: mFuc-TIV and
mFuc-TIX by a reverse transcription-polymerase chain reac-
tion (RT-PCR) method to show if one or both Fuc-T genes
were involved during RA-induced neural di¡erentiation.
2. Materials and methods
2.1. Materials and cells
GDP-[14C]Fuc (10.1 GBq/mol) was from NEN Life Science (NY,
USA). RA, cytosine arabinoside, GDP-Fuc, CDP-choline, fucose
(Fuc), and asialofetuin were from Sigma (MO, USA). LNnT (lacto-
N-neotetraose, GalL1-4GlcNAcL1-3GalL1-4Glc)-PA was synthesized
by pyridylamination of LNnT (Dextra, Reading, UK) using a reagent
kit (Takara, Otu, Japan). Paragloboside (GalL1-4GlcNAcL1-3Gal-
L1-4GlcL1-1Cer) (LNnT-Cer) was from Dia-Iatron (Tokyo, Japan).
Bovine brain CMH (GalL1-1Cer), CDH (GalL1-4GlcL1-1Cer) and
GA1 (asialo-GM1, GalL1-3GalNAcL1-4GalL1-4GlcL1-1Cer), human
erythrocytes CTH (GalK1-4GalL1-4GlcL1-1Cer) and globoside (Gal-
NAcL1-3GalK1-4GalL1-4GlcL1-1Cer) and sheep erythrocytes Forss-
man (GalNAcK1-3GalNAcL1-3GalK1-4GalL1-4GlcL1-1Cer) glycolip-
ids were from Sigma. Neoglycolipids, LNnT-L-1,2-dihexadecyl-sn-
glycero-phosphoethanolamine (DHPE) and LNFP-III (lacto-N-fuco-
pentaose-III, GalL1-4(FucK1-3)GlcNAcL1-3GalL1-4Glc)-DHPE were
prepared by conjugation of oligosaccharide standards (Dextra, Read-
ing, UK) to DHPE (Fluka, Gillingham, UK) as described by Feizi et
al. [19]. Speci¢c anti-Lex MAb, clone 73-30 [20], was from Seikagaku
(Tokyo, Japan). Horseradish peroxidase-conjugated anti-mouse im-
munoglobulins antibody was from Amersham Pharmacia Biotech
(Buckinghamshire, UK). P19 EC cells (kindly provided by Dr. H.
Hamada of Osaka University, Osaka, Japan) were cultured as previ-
ously described [17,18]. Three types of cells were used in this study:
untreated, RA-induced aggregates and di¡erentiated neural cells. All
di¡erentiated neural cells were shown to express neural marker pro-
teins by immunohistochemical analysis using anti-GAP-43, and -syn-
aptophysin MAbs in addition to morphological changes observed
under the microscope [21].
2.2. Extraction of neutral glycolipids and thin-layer chromatography
(TLC)-immunostaining
Total lipids were extracted from 109 cells and were separated into
neutral and acidic fractions by DEAE Sephadex A-25 (acetate form)
according to Ledeen and Yu [22]. The total neutral glycolipids ob-
tained from untreated cells, RA-induced aggregates and di¡erentiated
neural cells were 1.8 mg, 2.3 mg, and 3.1 mg (dry weight), respectively,
and they were resolved on silica gel 60 high-performance TLC plates
(HPTLC, Merck, Darmstadt, Germany) using the following solvent
systems: solvent (A), CHCl3/MeOH (1/1, v/v) and solvent (B), CHCl3/
MeOH/0.2% CaCl2 (60/40/10, v/v/v). The resolved neutral glycolipids
were stained with orcinol and primuline [19,23] and identi¢ed by
comparing with commercial standards. TLC-immunostaining with
anti-Lex MAb was carried out similar to previously described [18].
Brie£y, neutral glycolipids (2 Wg) were resolved on HPTLC plate,
stained with primuline, visualized and photographed under ultraviolet
light (UV) at 365 nm [23]. Since preliminary experiments showed that
all immunoreactive bands were found below the spot of GA1, sample
plates from subsequent studies were therefore cut and only the immu-
noreactive portion was investigated further. The cut plate was ¢rst
plasticized by dipping into 0.05% polyisobutyl methacrylate (Plexigum
P28; Merck, Darmstadt, Germany) in cyclohexane for 2 min and air-
dried. After wetting with phosphate-bu¡ered saline (PBS), the plate
was then submerged in PBS containing 3% bovine serum albumin
(BSA) at room temperature for 1.5 h, overlaid with anti-Lex MAb
(diluted 1:100 with PBS containing 3% BSA) and incubated at room
temperature for 1.5 h. After washing three times with PBS, immuno-
reactive bands were visualized using a Vectastain ABC kit (Vector
Lab., CA, USA) and DAB substrate kit (Funakoshi, Tokyo, Japan)
according to suppliers’ instructions. Color development was stopped
by dipping into PBS. A study on the acidic glycolipid fraction had
already been reported elsewhere [18].
2.3. Analysis of neutral oligosaccharides and neoglycolipids
For the identi¢cation of Lex bearing oligosaccharide structures,
neutral glycolipids extracted from 5U109 RA-induced aggregates
were treated with endoglycoceramidase (Seikagaku) according to the
supplier’s instructions. After passing through a Sep-Pak C18 cartridge
(500 mg, Waters, Watford, UK) and desalted on a mixed bed column
containing AG50-X12 (H form) and AG3-X4 (OH form) resins (Bio-
Rad, CA, USA), the released neutral oligosaccharides were estimated
for hexose (Hex) contents [19] and then fractionated on a TSK
Amide-80 column (4.6U250 mm, Anachem, Luton, UK) using aceto-
nitrile/water (elution gradient was from 35% to 50% aqueous in 40 min
at a £ow rate of 1 ml/min; detection was by UV at 205 nm). Sixteen
fractions were collected (Fig. 2A), lyophilized and conjugated to
DHPE [19]. Lex immunoreactive components in these neoglycolipid
fractions were identi¢ed by TLC-immunostaining as described above
after their separation on HPTLC plates using CHCl3/EtOH/H2O
(45/60/15, v/v/v) as solvent (Fig. 2B,C). The immunoreactive frac-
tions: 7, 10 and 12 were further subjected to in situ TLC-liquid sec-
ondary ion mass spectrometry (LSIMS) analysis. LSIMS was per-
formed on a VG ZAB 2E mass spectrometer in negative-ion mode.
Spectra were acquired directly from TLC plate surface as previously
described [24,25].
2.4. Assay of Fuc-Ts
Glycolipid, glycoprotein and PA-oligosaccharide Fuc-Ts were as-
sayed using appropriate acceptor and donor substrates. Cells (108)
were suspended in 100 Wl of 0.5 M sucrose in PBS containing 0.3%
Triton X-100 detergent, sonicated (0.5 cycle, 90% amplitude; UP 50H,
Kubota, Japan), and used as enzyme source. The determinations of
these three Fuc-T enzyme activities were optimized and linear up to
4 h under the present conditions. Brie£y, glycolipid Fuc-T activity was
assayed in 20 Wl of 0.1 M HEPES, pH 7.0 containing 6 Wg paraglobo-
side (LNnT-Cer, acceptor substrate), 100 WM GDP-[14C]Fuc, 5 mM
CDP-choline (phosphodiesterase inhibitor), 10 mM Fuc (fucosidase
inhibitor), 20 mM MnCl2 and 10 Wl enzyme source [26]. After incu-
bation at 37‡C for 2 h, the radio-labeled product was measured as
previously reported [18]. Glycoprotein Fuc-T activity was measured in
20 Wl of 0.1 M HEPES, pH 8.0 containing 100 Wg asialofetuin (accep-
tor substrate), 100 WM GDP-[14C]Fuc, 5 mM CDP-choline, 10 mM
Fuc, 20 mM CaCl2, and 10 Wl enzyme source. After incubation at
37‡C for 2 h, the reaction mixture was spotted onto Whatman No. 1
paper (2U2 cm), ¢xed by dipping into 10% (w/v) trichloroacetic acid,
rinsed twice with fresh 10% (w/v) trichloroacetic acid and then rinsed
once with EtOH/diethyl ether (2/1, v/v). Radioactivity on the paper
was measured using a liquid scintillation counter. PA-oligosaccharide
Fuc-T activity was measured in 20 Wl of 0.1 M HEPES, pH 8.0 con-
taining 0.1 mM LNnT-PA (acceptor substrate), 1 mM GDP-Fuc,
5 mM CDP-choline, 10 mM Fuc, 20 mM CaCl2 and 10 Wl enzyme
source. After incubation at 37‡C for 2 h, the reaction was stopped by
boiling for 5 min and centrifuged at 10 000 rpm for 5 min. 10 Wl of
supernatant was then subjected to high-performance liquid chroma-
tography (HPLC) analysis on a PALPAK Type N column (Takara,
Otu, Japan), by isocratic elution with acetonitrile/200 mM acetic acid-
triethylamine (69/31, v/v), pH 7.3, at a £ow rate of 1.0 ml/min at
40‡C. Elution pro¢le was monitored by £uorescence (excitation and
emission wavelengths at 320 and 400 nm, respectively) and the
amounts of the products were determined by comparing their £uores-
cence intensities to the standard, LNnT-PA (Takara, Otu, Japan).
Protein concentration was determined using Micro BCA Protein As-
say Reagent kit (Pierce, IL, USA). Relative enzyme activities were
expressed as CPM[14C]Fuc/mg protein/h for the glycolipid and glyco-
protein Fuc-Ts. The PA-oligosaccharide Fuc-T activity was expressed
as LNnT-Fuc-PA pmol/mg protein/h.
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2.5. Analysis of Fuc-T transcripts using RT-PCR methods
Total RNA was extracted from 109 untreated cells, RA-induced
aggregates, and di¡erentiated neural cells using ISOGEN reagent
(Nippon gene, Tokyo, Japan) and 5 Wg of it was treated with
RNase-free DNase I (Boehringer Mannheim, Germany) at 37‡C for
10 min to remove residual genomic DNA. It was followed by incu-
bation at 95‡C for 15 min to inactivate DNase I. Complementary
DNA (¢rst strand cDNA) was synthesized with an oligo (dT) primer
from 1 Wg of the DNase I-treated total RNA in a 20 Wl total volume
reaction mixture using a SUPERSCRIPT II kit (Life Technologies,
MD, USA). 1 Wl aliquot of the ¢rst strand cDNA was ampli¢ed by
PCR in 50 Wl reaction mixture containing 0.2 WM of each primer,
0.2 mM dNTP and 1.25 U of AmpliTaqGold (Perkin-Elmer, NJ,
USA) with a pre-PCR heating step at 95‡C for 9 min, followed by
optimal numbers of PCR cycles at 95‡C for 45 s, 63‡C for 45 s and
72‡C for 1 min (40 cycles for mFuc-TIV and mFuc-TIX, and 30 cycles
for hypoxanthine phosphoribosyltransferase (HPRT), the transcript
expression control). For analysis, 10 Wl aliquot of PCR products
and appropriate bp molecular marker standards (Gibco BRL, NY,
USA) were electrophoresed on a 1% agarose gel and stained with
ethidium bromide. Primer sets used were as described previously
[14]: mFuc-TIV forward, 5P-TTGCAGCCTGCGCTTCAACATC-
AG-3P ; mFuc-TIV reverse, 5P-ACTCAGCTGGTGGTAGTAACG-
GAC-3P ; mFuc-TIX forward, 5P-CAGCTGGGATCTGACTAACT-
TACC-3P ; mFuc-TIX reverse, 5P-CCACATGAATGAATGAATCA-
GCTGG-3P ; HPRT forward, 5P-TGACCTGCTGGATTACATTAA-
AGCACT-3P, and HPRT reverse, 5P-ATAGTCAAGGGCATATC-
CAACAACAAA-3P.
3. Results
3.1. Structures of extracted neutral glycolipids
Globoside and Forssman were shown to be the major neu-
tral glycolipid components in the three P19 EC cell types:
untreated, RA-induced aggregates and RA-induced neural
cells. Lex immunoreactive components were present in all
but only in minute quantities. However, glycolipids bearing
Lex epitope were noticeably increased in both the aggregates
and neural cells (Fig. 1B, lanes 2 and 3), when compared to
untreated cells (Fig. 1B, lane 1). These Lex epitope bearing
glycolipids also had a slower TLC mobility than GA1, indi-
cating that they contained oligosaccharide moieties larger
than tetrasaccharide (Fig. 1A).
In order to increase the chance of determining oligosaccha-
ride structures from limited glycolipid materials, oligosaccha-
rides were ¢rst released by endoglycoceramidase from total
neutral glycolipids extracted from RA-induced aggregates.
The oligosaccharides released (40 Wg Hex, as determined by
orcinol staining [19]) were then fractionated by normal phase
HPLC. Sixteen fractions were collected and oligosaccharides
recovered in each fraction were converted into neoglycolipids
(Fig. 2A). A portion of neoglycolipids (10%) were used for
TLC-immunostaining with anti-Lex MAb and Lex immunore-
activity was found in fractions 7 (pentasaccharide region), 10
(heptasaccharide region) and 12 (octasaccharide region) (Fig.
2B,C). These Lex immunoreactive neoglycolipids were ana-
lyzed by in situ TLC-LSIMS and their carbohydrate compo-
sitions, sequences and probable structures are summarized in
Table 1. In fraction 7, two closely resolved neoglycolipid
bands of equal intensity were found and gave LSI spectra
having [M-H]3 ions at m/z 1499 (upper band) and m/z 1515
(lower band). Fragmentation ions in the spectrum (Fig. 3) of
the upper band at m/z 826, 988, 1337, 1353, together with a
singlet ion at m/z 1157, diagnostic of a Fuc branch [25],
clearly identi¢ed a pentasaccharide sequence with a non-re-
ducing terminal Fuc branch. Since this band was Lex immu-
noreactive, the structure was deduced to be GalL1-4(FucK1-
3)GlcNAc-Hex-Hex-DHPE. The non-immunoreactive lower
band contained no Fuc as indicated by [M-H]3 at m/z 1515
and sequence ions at m/z 826, 988, 1191, and 1353, corre-
sponding to Hex-Hex-HexNAc-Hex-Hex-DHPE. Similarly,
fraction 10 gave two incompletely resolved neoglycolipid
bands. The upper minor band, which was Lex immunoreac-
tive, gave an [M-H]3 at m/z 1864 and partial sequence ions,
from which the GalL1-4(FucK1-3)GlcNAc-Hex-HexNAc-Hex-
Hex-DHPE sequence was deduced. The lower non-immuno-
reactive band contained no Fuc as indicated by a composition
Fig. 1. TLC and immunostaining analyses of neutral glycolipids from P19 EC cells. TLC of neutral glycolipids extracted from undi¡erentiated
and RA-treated di¡erentiated P19 EC cells. The samples, 2 Wg lipids, were developed on a HPTLC plate with solvent systems: (A) CHCl3/
MeOH (1/1, v/v), followed by (B) CHCl3/MeOH/0.2% CaCl22H2O (60/40/10, v/v/v). A: Primuline staining. B: Immunostaining analysis of the
same TLC plate (A) with anti-Lex MAb. Lanes: 1, undi¡erentiated cells ; 2, RA-induced aggregates; 3, RA-induced neural cells ; St1, glycolipid
standards (arrow heads point to the relative positions of CMH, CDH, CTH, globoside, Forssman and GA1, respectively) and St2, neoglyco-
lipid standard, LNFP-III-DHPE (the strong £uorescence band near the CDH position is DHPE reagent). ‘Origin’ points to the position of
sample application.
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Fig. 2. HPLC, TLC and immunostaining analyses of oligosaccharides released from neutral glycolipids of RA-induced aggregates. A: Normal
phase HPLC fractionation of oligosaccharides released by endoglycoceraminidase from total neutral glycolipids. Oligosaccharide fractions (num-
bers 1^16) were collected and converted to DHPE neoglycolipids (see B). Numbers with a star are fractions where positive Lex immunoreactivi-
ty was found (see C). Arrow indicates elution position of the oligosaccharide standard, LNFP-III. B: Primuline staining; C: immunostaining
analysis of the same TLC plate (B) with anti-Lex MAb. Neoglycolipids (spots 1^16) prepared from the corresponding oligosaccharides fractions
in A were ¢rst resolved by HPTLC with solvent CHCl3/EtOH/H2O (45/60/15, v/v/v) and then immunostained with anti-Lex MAb; St, neoglyco-
lipid standards (arrow heads point to the LNnT-DHPE and LNFP-III-DHPE). Arrow with ‘origin’ indicates the position of sample applica-
tion.
Fig. 3. LSI mass spectrum of the upper neoglycolipid band from neutral oligosaccharide HPLC fraction 7. The assignment of the oligosaccha-
ride-DHPE structure was made from the deprotonated molecule m/z 1499 and the sequence ions m/z 1353, 1337, 988 and 826. The singlet ion
m/z 1157 is diagnostic of a Fuc branch [25]. Full interpretation is in Section 3.1.
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of (Hex2.HexNAc)-Hex-HexNAc-Hex-Hex-DHPE deduced
from a [M-H]3 at m/z 1880 and partial sequence ions. In
fraction 12, two unresolved neoglycolipid bands were present
but at too low intensity to obtain sequence ions. However, the
[M-H]3 at m/z 2010 (upper part) and [M-H]3 at 2026 (lower
part) were consistent with the respective compositions of
(dHex2.Hex4.HexNAc2)-DHPE and (dHex.Hex5.HexNAc2)-
DHPE. Since both bands were immunoreactive to anti-Lex
MAb, the oligosaccharide structures were likely to be
GalL1-4(FucK1-3)GlcNAc-(dHex.Hex3.HexNAc)-DPHE and
GalL1-4(FucK1-3)GlcNAc-(Hex4.HexNAc)-DHPE, respec-
tively.
The lipid chains of the Lex epitope bearing glycolipids were
also analyzed by TLC-LSIMS. The majority of the Cer moi-
ety (with a mass of 564) was deduced to contain a total of 34
carbon atoms, one hydroxyl group and one double bond.
Because of limited materials available the detailed structures
of the Cer chains could not be identi¢ed.
3.2. Fuc-T activities
Glycolipid, glycoprotein and oligosaccharide Fuc-T activ-
ities were all increased in both of the two RA-induced cell
types with the highest activity found in the di¡erentiated neu-
ral cells (Fig. 4A^C, lane 3). The oligosaccharide Fuc-T ac-
tivity in RA-induced neural cells showed a 30-fold higher
activity than the undi¡erentiated cells (Fig. 4C, lanes 1 and
3, respectively).
3.3. Expressions of mouse Fuc-TIV and Fuc-TIX genes by
RT-PCR analysis
The mFuc-TIV transcript, 511 bp (Fig. 5A, was only ex-
pressed in RA-induced aggregates and was not detected in
undi¡erentiated cells nor in RA-induced neural cells. On the
other hand, the mFuc-TIX transcript, 530 bp (Fig. 5B), was
detectable in all three cell types. It was weakly expressed in
undi¡erentiated cells but visibly much stronger in RA-induced
aggregates and stronger still in RA-induced neural cells. The
control HRPT transcript (357 bp) was expressed at similar
levels in all cell types (Fig. 5C). From these results, we con-
cluded that RA induces only a transient expression of the
mFuc-TIV gene in cell aggregates but a more persistent ex-
pression of the mFuc-TIX gene at the transcription level
throughout neural cell di¡erentiation.
4. Discussion
The biological relevance for the presence of these Lex bear-
ing glycans is interesting. Boubelik et al. [27] indicated that
surface carbohydrates were involved in cadherin-mediated cell
sorting in the absence of mixed aggregates formed between
parental and Lex- or embryoglycan-negative mutant P19 cells.
In our present study, Lex epitope bearing glycolipids were
markedly increased with concomitant elevation of Fuc-T ac-
tivities during RA-induced neural di¡erentiation of P19 EC
cells. Our ¢ndings on Fuc-T gene transcripts also support that
Table 1
Partial sequence of the major Lex epitope bearing oligosaccharides released from P19 EC cell neutral glycolipids obtained by TLC-LSIMS of
the derived neoglycolipids
HPLC fractions [M-H]3 Deduced structures
7 upper 1499 GalL1-4(FucK1-3)GlcNAc-Hex-Hex
10 upper 1864 GalL1-4(FucK1-3)GlcNAc-Hex-HexNAc-Hex-Hex
12 upper 2010 GalL1-4(FucK1-3)GlcNAc-(dHex.Hex3.HexNAc)
lower 2026 GalL1-4(FucK1-3)GlcNAc-(Hex4.HexNAc)
Monosaccharide sequences established by fragment ions are indicated by a dash (-) and otherwise compositions are given as indicated by a pe-
riod (.). [M-H]3, deprotonated molecular ion; GalL1-4(FucK1-3)GlcNAc-, Lex epitope; Hex, hexose; dHex, deoxyhexose; HexNAc, N-acetyl-
hexosamine.
Fig. 4. Fuc-T activities in P19 EC cells before and after treatment with RA. A: Glycolipid Fuc-T activities; B: glycoprotein Fuc-T activities
and C: PA-oligosaccharide Fuc-T activities. Lanes 1, undi¡erentiated cells ; lanes 2, RA-induced aggregates and lanes 3, RA-induced neural
cells. Fuc-T activities were measured as described in Section 2 and were averages of two experiments.
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the mFuc-TIX gene and not mFuc-TIV was involved during
this type of neural di¡erentiation. Using the neoglycolipid
technology [19] and mass spectrometry, we were able to iso-
late and identify at least four Lex epitope bearing oligosac-
charide chains from the very limited amounts of neutral gly-
colipids extracted from these cells. The shortest structure was
a pentasaccharide with a partial sequence of GalL1-4(FucK1-
3)GlcNAc-Hex-Hex-. A heptasaccharide, GalL1-4(FucK1-3)-
GlcNAc-Hex-HexNAc-Hex-Hex-, and two octasaccharides,
GalL1-4(FucK1-3)GlcNAc-dHex.Hex3.HexNAc- and GalL1-
4(FucK1-3)GlcNAc-(Hex4.HexNAc)-, each containing either
one or two Fuc residues, had also been deduced and partially
sequenced. Recently, Nishihara et al. [28] reported that hu-
man Fuc-TIII, -TIV, -TV, and -TVI had very similar substrate
speci¢city and preferred the transfer of Fuc to the internal
GlcNAc residue of N-acetyl polylactosamine chain but Fuc-
TIX preferred the peripheral GlcNAc residue. More experi-
ments are therefore required to study particularly the acceptor
speci¢city for these Fuc-Ts using hexa-, octa-, or even longer
N-acetyl polylactosamine chains to confer the transfer of Fuc
to internal GlcNAc residue of glycolipids and glycoproteins.
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Fig. 5. Expression of mFuc-TIV, mFuc-TIX, and HRPT in P19 EC
cells by the RT-PCR analysis. Total RNAs were isolated from un-
di¡erentiated cells (U), RA-induced aggregates (R/A), and RA-in-
duced neural cells (R/N). Reverse transcription and ampli¢cation
were performed in the presence of RT (reverse transcriptase) as de-
scribed in Section 2. A: mFuc-TIV; B: mFuc-TIX and C: HRPT
which was used to normalize for variations in the amount and qual-
ity of RNA loaded in each lane. Aliquots of the reactions were elec-
trophoresed in 1% agarose gel and stained with ethidium bromide.
bp, base pair molecular weight markers; + or 3 indicates with or
without RT, respectively.
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